Alan Stolier, MD, FACS

Alan Stolier, MD, FACS

Dr. Alan Stolier

Dr. Stolier, MD, FACS, clinical breast oncologist, shares Educational and Scientific News Articles

Hear From Our Patients

Dr. Stolier & Dr. Wise are simply amazing. The staff at the Breast Center are truly second to none. Everyone there did their absolute best to make sure my stay was as comfortable as possible.


Dr. Alan Stolier, MD, FACS has over 35 years experience in surgical oncology. He specializes in surgical treatment of breast cancer, and is a pioneer in the development of nipple-sparing mastectomy.

Dr. Stolier first collaborated with Drs. DellaCroce and Sullivan in his tenure as the first medical director of the Breast Center at Memorial Hospital in New Orleans.  Board Certified in Surgery, he now brings tremendous experience and expertise to the surgical team at the Center for Restorative Breast Surgery.

He received his medical degree from Louisiana State University School of Medicine. Following his Surgical Internship at the University of Virginia Hospital, Dr. Stolier returned to New Orleans to begin his Residency in General Surgery at Charity Hospital of Louisiana. He then completed Fellowships in Surgical Oncology at MD Anderson Cancer Institute and Hammersmith Hospital in London, England. He is a fellow of the American College of Surgeons and is a member of numerous societies including the American Society of Breast Disease and the American Society of Breast Surgeons. Dr. Stolier has a particular interest in breast cancer genetics and the associated care of women with the BRCA genetic mutation.

He is past president of the New Orleans Surgical Society and has been a Clinical Professor of Surgery for the Tulane University Health Sciences Center since 2005. He is a Past Board Member of the LSU Medical Foundation and Memorial Medical Center and on the Professional Advisory Board of He has published nearly two-dozen articles pertaining to breast cancer and treatment of breast cancer in such publications as Annals of Surgical Oncology and American Journal of Surgery. He has lectured extensively throughout the United States and The American Cancer Society named Dr. Stolier a 2010 Spirit Award Honoree for going above and beyond in the fight against breast cancer.


1966, Louisiana State U. in New Orleans, B.S. Degree

Medical School:
1966-70, Louisiana State U. School of Medicine, M.D. Degree

Internship, Straight Surgery:
1970-71, University of Virginia Hospital, Charlottesville, VA

Residency in General Surgery:
1971-73, 75-76, Charity Hospital of Louisiana, New Orleans. LSU Service

Fellowships in Surgical Oncology:
1973-74, M.D. Anderson Cancer Institute, Houston TX
1974-75, Hammersmith Hospital , London England

Academic Positions:
2005-present: Clinical Professor of Surgery, Tulane University Health Sciences Center

Other Professional Appointments

1998-2000, Director of Breast Services, LSU Stanley S. Scott Cancer Center
1998-2000, Medical Director of The Breast Center, Memorial Medical Center, New Orleans LA
2000-2003 Medical Director Lieselotte Tansey Breast Center, Ochsner Clinic Foundation, New Orleans, LA

Board Certifications

American Board of Surgery, 1977, 1987, 1995, 2007

Awards / Honors

1988-89, 1989-90, Teaching award, “Faculty of the Year,” Tulane U. Dept. Surgery
1991, Program Chairman, Joint meeting of Louisiana Surgical Society and LA. Chapter, American College of Surgeons
1989-91, Treasurer, New Orleans Surgical Society
1993-94, President, New Orleans Surgical Society

Community Service

Board Member, Susan G. Komen Foundation
Board Member, Memorial Medical Center
Past Board Member, L.S.U. Medical Foundation

Book Chapter

Stolier A. Reducing the risk of nipple-areola necrosis. In Nipple-Sparing Mastectomy. John Wiley and Son in press

Stolier A. Surgical Considerations in Partial Breast Irradiation in Accelerated Partial Breast Irradiation, Second Edition. Editor: Springer 2009


Levine SM, Snider C, Gerald G, Tanna N, Broer N, Stolier A, Sadeghi A, Allen R. Buried Flap Reconstruction after Nipple-Sparing Mastectomy: Advancing toward Single-Stage Breast Reconstruction. Plast Reconstr Surg. 2013 Oct;132(4)

Wolfe E, Corsetti R, Bolton JS, Stolier AJ, Fuhrman GM. The evolution in management of patients with subcentimeter, node-negative, triple-negative breast cancer. Am J Surg. 2013 Oct 8 (epub ahead of print).

Stolier AJ, Levine EA. Reducing

Stolier AJ, Levine EA. Reducing the risk of nipple necrosis: technical observations in 340 nipple-sparing mastectomies. Accepted for publication in Breast Journal, 12/2011

Stolier AJ, Wang J. Terminal duct lobular units are scarce in the nipple: Implications for prophylactic nipple-sparing mastectomy. Ann of Surg Oncol 2008; 15: 438-442.

Stolier AJ, Sullivan SK, Dellacroce FJ. Technical Considerations in Nipple-sparing mastectomy: 82 consecutive cases without necrosis. Annals of Surgical Oncology 2008; 15: 1341-7

Cundiff j, Wang YZ, Espenan G, Maloney T, Camp A, Lazarus L, Stolier A et al. A Phase I/II Trial of 1251 Methylene Blue for one-stage sentinel lymph node biopsy. Ann Surg 2007; 245: 290-96

Stolier AJ, Grube BJ. Areola-sparing mastectomy: assessing the risk. J. Am College Surg.. 2005; 201:118-124.

Descriptions and Outcomes of Insertion Techniques of a Breast Brachytherapy BalloonCatheter in 1403 Patients Enrolled in the American Society of Breast Surgeons MammoSite™ Breast Brachytherapy Registry TrialZannis V a, , Beitsch P b, Vicini F c ,Quiet C d, Keleher A e, Garcia D f, Snider H g, Gittleman M h , Kuerer H i, Whitacre E j, Whitworth P k, Fine R l, Haffty B m, Stolier, A n, Arrambide, S o Accepted for publication, American Journal of Surgery

Stolier A, Fuhrman GM, Scroggings TG, Boyer CI. Postlumpectomy insertion of the Mammosite brachytherapy device using the scar entry technique. Breast J. 2005 May-Jun;11(3):199-203.

Farkas EA, Stolier AJ, Teng SC, Bolton JS, Fuhrman GM. An Argument against routine sentinel node mapping for DCIS. Am Surg 2004; 70:13-17.

AJ Stolier, GM Fuhrman, L Mauterer, JS Bolton, DW Superneau. Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA1 or BRCA2 mutation. The Breast Journal 2004; 10:475-80.

Blessing WD, Stolier AJ, Teng SC, Bolton JS, Fuhrman GM. A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping. Am J Surg. 2002; 184:341-5.

Timothy SK, Teng S, Stolier AJ, Bolton JS, Fuhrman GM. Postmastectomy radiation in patients with four or more positive nodes. Am Surg. 2002; 68:539-44

Stolier AJ, Allen R, Linares L. Breast Conservation therapy with concomitant breast reduction in large breasted women. Breast J 2003; 9: 267-9.

Stolier AJ, Breast lymphatic mapping using blue dye and radiocolloid. J Am Coll Surg 2002; 194: 681. (letter to the editor)

Stolier AJ, Rupley DG. The impact of image directed core biopsy on the practice of breast surgery: a new algorithm for a changing technology. Am Surg 1997; 63;827-30.

Stolier AJ. Stereotactic breast biopsy: a surgical series. J Am Coll Surg 1997; 185: 224-28

Stolier AJ, Mera R, Schapira MD. The impact of current use of hormone replacement therapy on prognostic factors and surgical treatment of new breast cancers. Oncology Reports 1998; 5: 61-4.

Stolier AJ, Skinner J, Levine E. A prospective study of the seeding of the skin after core biopsy of the breast, American J Surgery 2000; 180: 104-107.

Gulec SA, Stolier A. Lymphatic mapping techniques in breast cancer: Functional anatomical considerations. JNM 2000; 41 (5) Supp: 280P.

Gulec SA, Su J, O’Leary JP, Stolier A. Clinical utility of frozen section in sentinel node biopsy in breast cancer. Am Surg. 2001 Jun;67(6):529-32

King TA, Farr GH, Cederbom GJ, Smetherman DH, Bolton JS, Stolier AJ, Fuhrman GM. A mass on breast imaging predicts coexisting invasive carcinoma in patients with a core biopsy diagnosis of DCIS. Submitted for publication, Jan 01

Rao P, Levine E, Myers M, Prakash V, Watson J, Stolier A, Kopicko J, Kissinger P, Raj S, Raj M. Elevation of serum riboflavin carrier protein in Breast Cancer. Cancer Epidemiology, Biomarkers and Prevention 1999; 8: 985-90.

Stolier,AJ, Boak JL, Cooke TCJ. A study of the immuological aspects of secondary bone tumors.Bulletin de la Society internationale de churgie 1975; 34:293.

Cooke TCJ, Boak JL, Stolier AJ. Effects of anaesthesia on host resistance. Bulletin de la society internationale de churgie (abst). 1975; 34:306.

Boak JL, Stolier AJ, Tebbutt S. Host response of methylcholanthrene sarcoma and sheep red blood cell skeletel implants. Clinical Oncology 1977; 3: 345-51.


Benitez, Pamela R.1; Keisch, Martin E.2; Vicini, Frank3; Stolier, Alan4; Scroggins, Troy5; Walker, Alonzo6; White, Julia7; Hedberg, Peter8; Hebert, Mary9; Arthur, Doug12; Zannis, Vic10; Quiet, Coral11; Streeter, Oscar13; Silverstein, Mel14 Five-Year Results: The Initial Clinical Trial of MammoSite® Balloon Brachytherapy for Partial Breast Irradiation in Early-Stage Breast Cancer Presented American Society of Breast Surgeons Annual Meeting, May 2, 2007. Phoenix

Kuske RR, Bolton JS, Fuhrman G, McKinnon WM, Stolier A, Wilenzick RW, Goodin F, Scroggins TG, Jiang X. Wide volume brachytherapy alone for select breast cancers: the ten year experience of the Ochsner clinic.. Presented at ASTRO 4/6/00

Evaluation of serum riboflavin carrier protein levels as a new non-invasive marker for breast cancer detection. Abstract. Cancer Symposium, Society of Surgical Oncology. San Diego, CA, 3/26-3/29/98. Rao PN, Prakash V, Meyers M, Raj SG, Watson C, Kissinger P, Levine E Raj MHG, Stolier A.

Stolier AJ, Skinner J, Levine E. Needle tract seeding following core needle biopsy of the breast: a prospective study. Society of Surgical Oncology Annual Meeting, March 7, 1999, Orlando.

Wide volume brachytherapy alone for select breast cancers: the ten year experience of the Ochsner Clinic. Kuske RR, Bolton JS, Fuhrman G, McKinnon WM, Stolier A, Wilenzick RW, Goodin F, Scroggins,TG, Jiang X. Submitted 4/6/2000 to ASTRO Clinical Utility of frozen section in sentinel node biopsy in breast cancer. Gulec S, O’Leary P, Stolier A.
Southeastern Surgical Society, March 2001, Atlanta GA.

A multidisciplinary approach to image-guided core needle biopsy of the breast. King TA, Cederbom GJ, Farr GH, Smetherman DH, Champaign JL, Stolier AJ, Bolton JS, Teng SC, Fuhrman GM. Poster presentation, Southeastern Surgical Society, Atlanta, 2001.

A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping: a trial born out of necessity.Blessing WD, Stolier AJ, Teng SC, Bolton JS, Fuhrman GM. Presented at the Society of Breast Surgeons meeting, Boston, 4/28/02.

Utilization of a Resource Center Located within a Free Standing Breast Center by Newly Diagnosed Breast Cancer Patients , Mauterer L , Fuhrman G1, Xiaozhang J1, Stolier AJ2, presented at the National Interdisciplinary Breast Meeting (Breast Center Consortium), Feb 2004, Las Vegas.

Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk or brca1 or brca2 mutation AJ Stolier, GM Fuhrman, L Mauterer, JS Bolton, DW Superneau, presented at the American Society of Breast Surgeons meeting, April 2004, Las Vegas.

Breast conservation therapy for invasive lobular carcinoma: the impact of lcis in the surgical specimen on local recurrence and axillary node status Stolier AJ, Barré G, Fuhrman GM, Bolton JS, Looney S, presented at American Society of Breast Disease Annual Meeting: Boston 2004.

Stolier AJ, Staudinger EB, Smith M. Metachlorpramide decreases postoperative ileus after cholecystectomy. Southern Surgical Congress Poster Display, Jan. 23-26, 1989.


“Diagnosis and Treatment of early breast cancer” to A.F.T.E.R. New Orleans, 1980

“Surgical approach to the diagnosis and treatment of breast cancer” To the National Association of Oncology Nurses. New Orleans, 12/17/80

“Breast Cancer: Current surgical concepts” Terrebonne Nursing Symposium, Houma, LA 2/4/81

“Surgical Management of Cancer” 4th Annual Rehabilitation Conference for Social Workers and Clergy, American Cancer Society, New Orleans, 3/27/82

“Value of Reglan in decreasing post-cholecystectomy hospitalization” presented with Dr. Mark Smith at the spring meeting, New Orleans Surgical Society, 6/5/88

“Breast Cancer” to the Elite Council on Breast Cancer for St. Paul’s Insurance Co. New Orleans, 6/4/91

“Extensive Intraductal Component” Fall meeting of the New Orleans Surgical Society, 9/21/91

“Issues regarding hereditary breast cancer” Public forum, Memorial Medical Ctr. 10/27/96

“Office Management of common breast problems” and “Surgical options in the management of breast cancer” presented at the symposium “Clinical Management of Breast Disease for the Primary Care Physician”, New Orleans, 9/13/97

“Breast Cancer Genetics” and “Skin-sparing Mastectomy” presented at the 91st Annual Scientific Assembly, Southern Medical Association, Charlotte,NC 11/7/97

“Hereditary Breast Cancer” presented to the New Orleans Oncology Nurses Society, 4/8/98

“Office management of common breast problems” presented at Controversies in OB/GYN and all that Jazz, Jacksonville, FL, 11/13/98

“Hereditary Breast Cancer”, presented at Controversies in OB/GYN and all that Jazz, 11/13/98, Jacksonville FL

“Sentinel Node Biopsy” presented to surgical group for Bristol Myers, Lake Charles, LA 3/19/99

“Stereotactic Biopsy of the Breast”, presented to a surgical group for Ethicon , Lafayette, LA, 4/14/99

“Mammographic controversies”, presented to the Women’s Professional Counsel, New Orleans, 11/1/99

“Hereditary Breast Cancer, Are you wearing the right genes” Gulf South Educational Conference, Biloxi MS 10/5/02

“Surgical approach to newly diagnosed breast cancer patients at high risk for BRCA1,2 mutations”, 4/1/04, American Society of Breast Surgeons, Las Vegas

“Accelerated partial breast irradiation using the Mammosite, a surgical perspective” 4/12/04; John Wayne Cancer Institute, Los Angeles

“Hereditary Breast Cancer: Incorporating Genetic Testing into the clinical setting” 11/20/2004; Alexian Brothers Symposium: Breast Cancer: What’s on the Horizon. Chicago IL

Hereditary Breast Cancer: Are you wearing the right “genes”? 31st Annual Education Conference: National Cancer Registrars Association, New Orleans, LA

Accelerated partial breast irradiation using the MammoSite Device. The Breast Cancer Challenge. Branson MO, 2/20/2005

Hereditary Breast Cancer: Are you wearing the right genes. National Cancer Registrar’s Association 31st Annual Education Conference. New Orleans, LA 4/13/2005

Genetic Susceptibility Testing for Hereditary Breast Cancer; presented at Greater Dayton Cancer, Dayton, Ohio July 20, 2006

Incorporating Genetic testing into the clinic setting, presented at “Multidisciplinary Management of Breast Disease” sponsored by the Western Pennsylvania Hospital Department of Surgery. Pittsburgh, PA November 10, 2006

“Surgical considerations in partial breast irradiation” and “Patient Discussion and Patient Care in Breast Brachytherapy. “presented at 2007 School of Breast Brachytherapy and Breast Brachytherapy Physics. March 1,2007. Las Vegas, NV

“Nipple-sparing mastectomy: Is it Time?” The 4th Annual Helene Madeira Breast Cancer Symposium. Philadelphia, PA. 4/5/2008

Nipple-sparing mastectomy: Is it time 6/15/09 New York University Cancer Conference